Get the Stockscreener App
5.3957
0.81%
-0.0443
After Hours:
5.40
0.0043
+0.08%
Nextcure Inc stock is traded at $5.3957, with a volume of 2,456.
It is down -0.81% in the last 24 hours and up +11.60% over the past month.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
See More
Previous Close:
$5.44
Open:
$5.2241
24h Volume:
2,456
Relative Volume:
0.01
Market Cap:
$14.44M
Revenue:
-
Net Income/Loss:
$-58.52M
P/E Ratio:
-2.5817
EPS:
-2.09
Net Cash Flow:
$-45.03M
1W Performance:
+11.25%
1M Performance:
+11.60%
6M Performance:
+649.40%
1Y Performance:
+290.99%
1-Day Range:
$5.2241
$5.44
1-Week Range:
$4.77
$5.49
52-Week Range:
$0.224
$6.42
Nextcure Inc Stock (NXTC) Company Profile
Name
Nextcure Inc
Sector
Industry
Phone
240-399-4900
Address
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
Compare NXTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NXTC
Nextcure Inc
|
5.3957 | 14.69M | 0 | -58.52M | -45.03M | -2.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Nextcure Inc Stock (NXTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-22 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Mar-01-22 | Initiated | Ladenburg Thalmann | Buy |
| Mar-05-21 | Upgrade | Truist | Hold → Buy |
| Jan-15-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-16-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Jul-13-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Jul-13-20 | Downgrade | SunTrust | Buy → Hold |
| Jun-01-20 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-01-20 | Downgrade | The Benchmark Company | Buy → Hold |
| May-26-20 | Initiated | JMP Securities | Mkt Outperform |
| Mar-24-20 | Initiated | The Benchmark Company | Buy |
| Mar-02-20 | Initiated | ROTH Capital | Buy |
| Jan-13-20 | Initiated | SunTrust | Buy |
| Dec-05-19 | Initiated | Needham | Buy |
| Nov-26-19 | Initiated | BTIG Research | Buy |
| Jul-09-19 | Initiated | BofA/Merrill | Buy |
| Jun-03-19 | Initiated | Morgan Stanley | Overweight |
| Jun-03-19 | Initiated | Piper Jaffray | Overweight |
View All
Nextcure Inc Stock (NXTC) Latest News
Can NextCure Inc. recover in the next quarterQuarterly Trade Review & Risk Controlled Daily Plans - Newser
How to manage a losing position in NextCure Inc.Earnings Beat & Reliable Trade Execution Plans - Newser
Developing predictive dashboards with NextCure Inc. dataTrade Signal Summary & Free Community Supported Trade Ideas - Newser
NextCure Inc. stock trendline breakdownEarnings Summary Report & Accurate Entry/Exit Alerts - Newser
Long term hold vs stop loss in NextCure Inc.Portfolio Profit Report & Long-Term Growth Plans - Newser
Automated trading signals detected on NextCure Inc.2025 Year in Review & Verified Stock Trade Ideas - Newser
Advanced analytics toolkit walkthrough for NextCure Inc.Analyst Downgrade & Community Verified Watchlist Alerts - Newser
Real time scanner hits for NextCure Inc. explained2025 Dividend Review & Free High Accuracy Swing Entry Alerts - Newser
Applying Wyckoff theory to NextCure Inc. stockMarket Trend Report & Growth Focused Entry Reports - Newser
Does NextCure Inc. show high probability of rebound2025 Breakouts & Breakdowns & Technical Confirmation Alerts - Newser
Price action breakdown for NextCure Inc.Profit Target & Trade Opportunity Analysis - Newser
Using AI based signals to follow NextCure Inc.Quarterly Growth Report & Accurate Trade Setup Notifications - Newser
Will earnings trigger a reversal in NextCure Inc.July 2025 Pullbacks & Weekly High Conviction Trade Ideas - Newser
Custom watchlist performance reports with NextCure Inc.Insider Selling & Free Daily Entry Point Trade Alerts - Newser
Pattern recognition hints at NextCure Inc. upsideJuly 2025 Catalysts & Community Trade Idea Sharing Platform - Newser
Is now a turning point for NextCure Inc.Earnings Growth Report & Real-Time Volume Analysis - Newser
Will NextCure Inc. see short term momentum2025 Technical Patterns & Smart Investment Allocation Insights - Newser
Using data filters to optimize entry into NextCure Inc.2025 Top Gainers & High Win Rate Trade Tips - Newser
Earnings visualization tools for NextCure Inc.Earnings Overview Summary & Weekly Sector Rotation Insights - Newser
Risk vs reward if holding onto NextCure Inc.Oil Prices & Capital Protection Trade Alerts - Newser
Ranking NextCure Inc. among high performing stocks via toolsInflation Watch & Long Hold Capital Preservation Plans - Newser
How NextCure Inc. stock performs during market volatilityStop Loss & Accurate Trade Setup Notifications - Newser
Technical analysis overview for NextCure Inc. stockJuly 2025 Trade Ideas & Daily Stock Momentum Reports - Newser
Visualizing NextCure Inc. stock with heatmapsForecast Cut & Weekly Consistent Profit Watchlists - Newser
Real time pattern detection on NextCure Inc. stock2025 Volatility Report & Growth-Oriented Investment Plans - Newser
Backtesting results for NextCure Inc. trading strategiesM&A Rumor & Safe Entry Point Identification - Newser
Should you hold or exit NextCure Inc. nowLong Setup & Entry Point Confirmation Signals - Newser
How to recover losses in NextCure Inc. stockMarket Risk Report & Daily Stock Momentum Reports - Newser
Chart based analysis of NextCure Inc. trends2025 Pullback Review & Low Risk Growth Stock Ideas - Newser
Nextcure Inc Stock (NXTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):